Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

BACKGROUND: The use of oral ribavirin (RBV) for respiratory syncytial virus (RSV) infections is not well studied. With the drastic increase in the cost of aerosolized RBV, we aimed to compare outcomes of hematopoietic cell transplant (HCT) recipients treated with oral or aerosolized RBV for RSV infe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: Foolad, Farnaz, Aitken, Samuel L, Shigle, Terri Lynn, Prayag, Amrita, Ghantoji, Shashank, Ariza-Heredia, Ella, Chemaly, Roy F
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Articles and Commentaries
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108094/
https://ncbi.nlm.nih.gov/pubmed/30202920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy760
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky